XERIS PHARMACEUTICALS INC Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2017-05-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-05-17; Total offering amount $44,999,999.
- 2016-12-30: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-12-31; Total offering amount $49,999,995.
- 2016-01-11: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-12-31; Total offering amount $49,999,995.
- 2014-09-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-09-17; Total offering amount $14,874,990.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2017-05-22 | Rule 506(b) | Equity | 2017-05-17 | $44,999,999 | $30,050,443 | $14,949,556 | 22 |
| 2016-12-30 D/A | Rule 506(b) | Equity | 2015-12-31 | $49,999,995 | $45,005,982 | $4,994,013 | 48 |
| 2016-01-11 | Rule 506(b) | Equity | 2015-12-31 | $49,999,995 | $41,005,980 | $8,994,015 | 47 |
| 2014-09-29 | Rule 506(b) | Equity | 2014-09-17 | $14,874,990 | $7,274,592 | $7,600,398 | 56 |